Risk of hyperkalemia in patients with moderate chronic kidney disease initiating angiotensin converting enzyme inhibitors or angiotensin receptor blockers: a randomized study

BACKGROUND: Angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers are renoprotective but both may increase serum potassium concentrations in patients with chronic kidney disease (CKD). The proportion of affected patients, the optimum follow-up period and whether there are dif...

Descripción completa

Detalles Bibliográficos
Autores principales: Espinel, Eugenia, Joven, Jorge, Gil, Iván, Suñé, Pilar, Renedo, Berta, Fort, Joan, Serón, Daniel
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750227/
https://www.ncbi.nlm.nih.gov/pubmed/23915518
http://dx.doi.org/10.1186/1756-0500-6-306

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3750227/
https://www.ncbi.nlm.nih.gov/pubmed/23915518
http://dx.doi.org/10.1186/1756-0500-6-306

Ejemplares similares